STEVEN H. SKLAR is a partner with Leydig‚ Voit & Mayer in Chicago where he has been practicing for over 23 years as a registered patent attorney. Mr. Sklar’s practice focuses on intellectual property matters with emphasis on patent litigation and counseling in the pharmaceutical, biotechnology and chemical fields. He has particular expertise on issues arising under the Hatch-Waxman Act including Paragraph IV patent litigation. In addition, Mr. Sklar is a frequent speaker and author on issues relating to pharmaceutical patents.
Drug products in which Mr. Sklar is currently representing generic pharmaceutical manufacturers in Paragraph IV litigation or has over the past several years include, for example, Suboxone film, Belbuca, Senispar, Nexium OTC, Butrans, Topicort, Differin, and MoviPrep. Most recently, he successfully represented Alvogen in litigation over its ANDA for Suboxone film initially at trial in the District of Delaware and then on appeal to the Federal Circuit.
Mr. Sklar graduated from the Northwestern University School of Law in 1996 and prior to that received a Bachelor of Science in Chemical Engineering from Washington University in St. Louis in 1991.
